News & Articles

Study suggests that type I IFN deficiency in the blood could help define a high-risk population

Science industry comes together online to share knowledge and provide technology solutions for cancer and immunology research

Register today to reserve a place at the Summit - it opens at 13:00 (BST) / 14:00 (CEST) / 08:00 (EDT) / 05:00 (PDT) on Monday, May 11

These models aim to accelerate treatment development prior to clinical trials

The combination of the unique technologies aims to bring a novel angle to combat the global pandemic

Explore a compilation of some of the most innovative technology news relating to the novel coronavirus and the COVID-19 disease

The only FDA-approved test that measures G6PD provides key insight to inform drug therapy options

Vehicle manufacturer utilizes infrastructure to expand production to face masks and gowns for frontline medical staff

Recognition comes as the publisher launches a series of Virtual Summits to support the science industry through the COVID-19 crisis

Oxford Cannabinoid Technologies has announced the pre-clinical development of a new cannabinoid compound ‘OCT461201’ to treat IBS

Samples from those who had COVID-19 could reveal true infection rate, lethality and vaccines

First commercial test will enable expedited coronavirus testing to meet urgent medical needs

Originally scheduled from March 11–15, the event has been postponed and will now take place from October 19–22, 2020

SciVario twin bioreactor control system: Designed for flexible and intuitive operation of a wide range of biological processes

Bubble buildup can hinder many industrial processes, but a new method can reduce or even eliminate it

Drop by SelectScience booth #205 at the SLAS2020 conference January 27-29

Thermo Fisher Scientific's forum focuses on strategies to expedite biotherapeutic development and commercialization

Tell us which new products made the most difference to your lab work and you’ll have the chance to win one of four $500 Amazon gift cards

Following last year’s success, we’re hosting our second annual event dedicated to celebrating our Seals of Quality program

Learn about the development of a new Zika vaccine at the Instituto Butantan and key technology for maintaining consistency in immunobiological product production

Complementary product portfolios will support and accelerate expansion into the pharmaceutical industry